COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04365933
Brief Title: A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

First Submitted : April 23, 2020
First Submitted that Met QC Criteria : April 27, 2020
First Posted : April 28, 2020

Last Update Submitted that Met QC Criteria : September 24, 2020
Last Update Posted : September 25, 2020